Oxyzo is thrilled to announce a groundbreaking funding milestone, having successfully raised 1,000,000,000 in capital to accelerate its mission of transforming small and medium enterprises (SMEs) into industry leaders. This new injection of funds comes at a pivotal time for Oxyzo, a company that has consistently demonstrated a profound understanding of the unique challenges and business needs of SMEs. With a proven track record of serving thousands of SMEs across India, disbursing over 4000+ crores per annum and managing assets under management exceeding 5000+ crores, Oxyzo has firmly established itself as a trusted partner in business growth and financial innovation.
The capital raised will be strategically deployed to further enhance its suite of customized credit solutions designed to empower SMEs to expand their operations, increase revenue, and improve profit margins. A cornerstone of Oxyzo’s offering is its dynamic approach to lending which includes pay-as-per-usage models, minimal documentation requirements, collateral-free options, and impressively quick 48-hour loan processing times. Additionally, with interest rates as competitive as 1.5% per month, Oxyzo continues to be the go-to option for businesses seeking both flexibility and affordability in credit solutions. The new funds are poised to bolster these offerings further, enabling the company to scale operations, invest in technology, and widen its market reach across India. Moreover, the funding will support initiatives that help SMEs access supplementary benefits, such as material savings through partnerships like With OfBusiness, where clients can save up to 3% on raw material purchases. This strategic investment not only underscores investor confidence in Oxyzo’s vision but also equips the company with enhanced resources to drive sustained growth and success for SMEs nationwide.
